Four Red Flags and One Truth Amid the Peptide Hype
Experimental peptides are all the rage on longevity and “optimization� podcasts, but a lot of the chatter is misleading.
The independent source for health policy research, polling, and news.
1-20 of 3,723 results
Experimental peptides are all the rage on longevity and “optimization� podcasts, but a lot of the chatter is misleading.
Amid a decline in youth mental health, momentum builds for a federal crackdown on social media companies over protections for kids.
People who have taken experimental peptides, such as BPC-157, complain of migraines, eye pain, fatigue, and more. Learning whether these popular but unproven drugs are to blame may become harder if Robert F. Kennedy Jr. fulfills a promise to make them more accessible.
Research shows natural gas pipelines — and the public health risks they carry — are concentrated in low-income and minority areas where people suffer higher rates of poverty and physical disabilities and have fewer means to respond to crises.
A new KFF poll suggests that health costs are still a top concern for voters and that Democrats have the edge over Republicans on the issue. And in an apparent attempt to close the gap, President Donald Trump is sending checks to millions of Medicare and Affordable Care Act enrollees. Anna Edney of Bloomberg News, Alice Miranda Ollstein of Politico, and Paige Winfield Cunningham of The Washington Sun join Ñî¹óåú´«Ã½Ò•îl Health News’ Julie Rovner to discuss these stories and more. Also, Rovner interviews Michelle Andrews, who wrote the latest Ñî¹óåú´«Ã½Ò•îl Health News “Bill of the Month.â€�
It’s been more than a year since President Donald Trump signed the One Big Beautiful Bill Act, and SNAP enrollment is down more than 20% in Louisiana. Anti-hunger groups say far more people could lose access if states are required to cover more of the food program’s cost.
Staff raced against rising floodwater to evacuate 36 residents from a nursing home in New Richland, Minnesota. It’s one of 100 facilities Ñî¹óåú´«Ã½Ò•îl Health News identified as facing some of the nation’s worst flood risk.
Recent outbreaks of foodborne illness and high-profile recalls have made this issue a concern of voters.
Healthcare in general, and health costs in particular, are a top issue for voters in 2026. But it remains unclear exactly how voters want lawmakers to fix the problem. Meanwhile, the Trump administration doubled down on its fraud-fighting efforts. Tami Luhby of CNN, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine, and Sarah Jane Tribble of Ñî¹óåú´«Ã½Ò•îl Health News join Ñî¹óåú´«Ã½Ò•îl Health News’ Julie Rovner to discuss these stories and more.
The disease has long been a risk of coal mining, an industry the Trump administration is trying to reinvigorate.
To get drugs and devices out faster, the FDA lets companies conduct studies of safety or efficacy after the products are approved. In many cases, such “postmarket� studies are behind schedule or overdue, records show.
Reports from a top AI company that it found and stopped attempted uses of its product to manufacture a potential bioweapon caught the attention of lawmakers in Washington this week. Meanwhile, President Trump wants to send $500 checks to about a million Obamacare enrollees. Anna Edney of Bloomberg News, Tami Luhby of CNN, and Alice Miranda Ollstein of Politico join Ñî¹óåú´«Ã½Ò•îl Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Sabrina Corlette of the Georgetown University Center on Health Insurance Reforms.
California is crafting weaker heat protections for prisons than other workplaces, citing billions in costs to cool aging institutions as climate and health risks increase. It’s a second-class standard, health and safety advocates say, and would leave correctional workers more susceptible to heat illness.
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
Amid a campaign already focusing on affordability, anxious voters are unlikely to be assuaged by headlines about healthcare costs rising even more next year. And a lawsuit that could cut off access nationwide to the abortion pill mifepristone gets a hearing in federal court. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine, Sandhya Raman of Bloomberg Law, and Amanda Seitz of Ñî¹óåú´«Ã½Ò•îl Health News join Ñî¹óåú´«Ã½Ò•îl Health News’ Julie Rovner to discuss these stories and more. Rovner also interviews Lauren Sausser, who wrote the latest Ñî¹óåú´«Ã½Ò•îl Health News “Bill of the Month.â€�
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
The agreements, covering issues like drug pricing, reducing the use of synthetic food dyes, and cutting back on insurance prior authorization rules, were announced with fanfare and touted as victories. But it’s not clear whether they’ll result in lasting change.
Opioid settlement cash was meant to abate the addiction crisis. But a new investigation reveals millions in Louisiana was spent on law enforcement gear and police technology instead of lifesaving treatment.
An analysis of hospital claims data in Florida found that firearm injuries of children disproportionately hit families in a handful of ZIP codes, almost all of them in Jacksonville, Orlando, Miami, or Tampa Bay.
Health workers are continuing to treat patients and train caregivers in the Democratic Republic of Congo, where the second-deadliest Ebola outbreak on record continues.
© 2026 KFF